Human KATP channelopathies

Diseases of metabolic homeostasis

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Assembly of an inward rectifier K+ channel pore (Kir6.1/Kir6.2) and an adenosine triphosphate (ATP)-binding regulatory subunit (SUR1/SUR2A/SUR2B) forms ATPsensitive K+ (KATP) channel heteromultimers, widely distributed in metabolically active tissues throughout the body. KATP channels are metabolism-gated biosensors functioning as molecular rheostats that adjust membrane potentialdependent functions to match cellular energetic demands. Vital in the adaptive response to (patho)physiological stress, KATP channels serve a homeostatic role ranging from glucose regulation to cardioprotection. Accordingly, genetic variation in KATP channel subunits has been linked to the etiology of life-threatening human diseases. In particular, pathogenic mutations in K ATP channels have been identified in insulin secretion disorders, namely, congenital hyperinsulinism and neonatal diabetes. Moreover, K ATP channel defects underlie the triad of developmental delay, epilepsy, and neonatal diabetes (DEND syndrome). KATP channelopathies implicated in patients with mechanical and/or electrical heart disease include dilated cardiomyopathy (with ventricular arrhythmia; CMD1O) and adrenergic atrial fibrillation. A common Kir6.2 E23K polymorphism has been associated with late-onset diabetes and as a risk factor for maladaptive cardiac remodeling in the community-atlarge and abnormal cardiopulmonary exercise stress performance in patients with heart failure. The overall mutation frequency within K ATP channel genes and the spectrum of genotype-phenotype relationships remain to be established, while predicting consequences of a deficit in channel function is becoming increasingly feasible through systems biology approaches. Thus, advances in molecular medicine in the emerging field of human KATP channelopathies offer new opportunities for targeted individualized screening, early diagnosis, and tailored therapy.

Original languageEnglish (US)
Pages (from-to)295-306
Number of pages12
JournalPflugers Archiv European Journal of Physiology
Volume460
Issue number2
DOIs
StatePublished - Jul 2010

Fingerprint

Channelopathies
KATP Channels
Metabolic Diseases
Homeostasis
Medical problems
Adenosine Triphosphate
Congenital Hyperinsulinism
Molecular Medicine
Inwardly Rectifying Potassium Channel
Physiological Stress
Systems Biology
Dilated Cardiomyopathy
Biosensing Techniques
Mutation Rate
Polymorphism
Metabolism
Biosensors
Adrenergic Agents
Atrial Fibrillation
Medicine

Keywords

  • ABCC8
  • ABCC9
  • ATP-sensitive K channels
  • Atrial fibrillation
  • Cardiomyopathy
  • Channelopathy
  • Diabetes
  • Disease
  • E23K
  • Genetics
  • Heart failure
  • Insulin
  • KCNJ11
  • Kir6.1
  • Kir6.2
  • KNCJ8
  • Mutation
  • Polymorphism
  • SUR1
  • SUR2A
  • SUR2B

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Physiology (medical)

Cite this

Human KATP channelopathies : Diseases of metabolic homeostasis. / Olson, Timothy Mark; Terzic, Andre.

In: Pflugers Archiv European Journal of Physiology, Vol. 460, No. 2, 07.2010, p. 295-306.

Research output: Contribution to journalArticle

@article{b6e81ae41f7646a792065cd155700ec9,
title = "Human KATP channelopathies: Diseases of metabolic homeostasis",
abstract = "Assembly of an inward rectifier K+ channel pore (Kir6.1/Kir6.2) and an adenosine triphosphate (ATP)-binding regulatory subunit (SUR1/SUR2A/SUR2B) forms ATPsensitive K+ (KATP) channel heteromultimers, widely distributed in metabolically active tissues throughout the body. KATP channels are metabolism-gated biosensors functioning as molecular rheostats that adjust membrane potentialdependent functions to match cellular energetic demands. Vital in the adaptive response to (patho)physiological stress, KATP channels serve a homeostatic role ranging from glucose regulation to cardioprotection. Accordingly, genetic variation in KATP channel subunits has been linked to the etiology of life-threatening human diseases. In particular, pathogenic mutations in K ATP channels have been identified in insulin secretion disorders, namely, congenital hyperinsulinism and neonatal diabetes. Moreover, K ATP channel defects underlie the triad of developmental delay, epilepsy, and neonatal diabetes (DEND syndrome). KATP channelopathies implicated in patients with mechanical and/or electrical heart disease include dilated cardiomyopathy (with ventricular arrhythmia; CMD1O) and adrenergic atrial fibrillation. A common Kir6.2 E23K polymorphism has been associated with late-onset diabetes and as a risk factor for maladaptive cardiac remodeling in the community-atlarge and abnormal cardiopulmonary exercise stress performance in patients with heart failure. The overall mutation frequency within K ATP channel genes and the spectrum of genotype-phenotype relationships remain to be established, while predicting consequences of a deficit in channel function is becoming increasingly feasible through systems biology approaches. Thus, advances in molecular medicine in the emerging field of human KATP channelopathies offer new opportunities for targeted individualized screening, early diagnosis, and tailored therapy.",
keywords = "ABCC8, ABCC9, ATP-sensitive K channels, Atrial fibrillation, Cardiomyopathy, Channelopathy, Diabetes, Disease, E23K, Genetics, Heart failure, Insulin, KCNJ11, Kir6.1, Kir6.2, KNCJ8, Mutation, Polymorphism, SUR1, SUR2A, SUR2B",
author = "Olson, {Timothy Mark} and Andre Terzic",
year = "2010",
month = "7",
doi = "10.1007/s00424-009-0771-y",
language = "English (US)",
volume = "460",
pages = "295--306",
journal = "Pfl{\"u}gers Archiv - European Journal of Physiology",
issn = "0031-6768",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Human KATP channelopathies

T2 - Diseases of metabolic homeostasis

AU - Olson, Timothy Mark

AU - Terzic, Andre

PY - 2010/7

Y1 - 2010/7

N2 - Assembly of an inward rectifier K+ channel pore (Kir6.1/Kir6.2) and an adenosine triphosphate (ATP)-binding regulatory subunit (SUR1/SUR2A/SUR2B) forms ATPsensitive K+ (KATP) channel heteromultimers, widely distributed in metabolically active tissues throughout the body. KATP channels are metabolism-gated biosensors functioning as molecular rheostats that adjust membrane potentialdependent functions to match cellular energetic demands. Vital in the adaptive response to (patho)physiological stress, KATP channels serve a homeostatic role ranging from glucose regulation to cardioprotection. Accordingly, genetic variation in KATP channel subunits has been linked to the etiology of life-threatening human diseases. In particular, pathogenic mutations in K ATP channels have been identified in insulin secretion disorders, namely, congenital hyperinsulinism and neonatal diabetes. Moreover, K ATP channel defects underlie the triad of developmental delay, epilepsy, and neonatal diabetes (DEND syndrome). KATP channelopathies implicated in patients with mechanical and/or electrical heart disease include dilated cardiomyopathy (with ventricular arrhythmia; CMD1O) and adrenergic atrial fibrillation. A common Kir6.2 E23K polymorphism has been associated with late-onset diabetes and as a risk factor for maladaptive cardiac remodeling in the community-atlarge and abnormal cardiopulmonary exercise stress performance in patients with heart failure. The overall mutation frequency within K ATP channel genes and the spectrum of genotype-phenotype relationships remain to be established, while predicting consequences of a deficit in channel function is becoming increasingly feasible through systems biology approaches. Thus, advances in molecular medicine in the emerging field of human KATP channelopathies offer new opportunities for targeted individualized screening, early diagnosis, and tailored therapy.

AB - Assembly of an inward rectifier K+ channel pore (Kir6.1/Kir6.2) and an adenosine triphosphate (ATP)-binding regulatory subunit (SUR1/SUR2A/SUR2B) forms ATPsensitive K+ (KATP) channel heteromultimers, widely distributed in metabolically active tissues throughout the body. KATP channels are metabolism-gated biosensors functioning as molecular rheostats that adjust membrane potentialdependent functions to match cellular energetic demands. Vital in the adaptive response to (patho)physiological stress, KATP channels serve a homeostatic role ranging from glucose regulation to cardioprotection. Accordingly, genetic variation in KATP channel subunits has been linked to the etiology of life-threatening human diseases. In particular, pathogenic mutations in K ATP channels have been identified in insulin secretion disorders, namely, congenital hyperinsulinism and neonatal diabetes. Moreover, K ATP channel defects underlie the triad of developmental delay, epilepsy, and neonatal diabetes (DEND syndrome). KATP channelopathies implicated in patients with mechanical and/or electrical heart disease include dilated cardiomyopathy (with ventricular arrhythmia; CMD1O) and adrenergic atrial fibrillation. A common Kir6.2 E23K polymorphism has been associated with late-onset diabetes and as a risk factor for maladaptive cardiac remodeling in the community-atlarge and abnormal cardiopulmonary exercise stress performance in patients with heart failure. The overall mutation frequency within K ATP channel genes and the spectrum of genotype-phenotype relationships remain to be established, while predicting consequences of a deficit in channel function is becoming increasingly feasible through systems biology approaches. Thus, advances in molecular medicine in the emerging field of human KATP channelopathies offer new opportunities for targeted individualized screening, early diagnosis, and tailored therapy.

KW - ABCC8

KW - ABCC9

KW - ATP-sensitive K channels

KW - Atrial fibrillation

KW - Cardiomyopathy

KW - Channelopathy

KW - Diabetes

KW - Disease

KW - E23K

KW - Genetics

KW - Heart failure

KW - Insulin

KW - KCNJ11

KW - Kir6.1

KW - Kir6.2

KW - KNCJ8

KW - Mutation

KW - Polymorphism

KW - SUR1

KW - SUR2A

KW - SUR2B

UR - http://www.scopus.com/inward/record.url?scp=77955569283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955569283&partnerID=8YFLogxK

U2 - 10.1007/s00424-009-0771-y

DO - 10.1007/s00424-009-0771-y

M3 - Article

VL - 460

SP - 295

EP - 306

JO - Pflügers Archiv - European Journal of Physiology

JF - Pflügers Archiv - European Journal of Physiology

SN - 0031-6768

IS - 2

ER -